Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06644222
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-08
Brief Title:
Effectiveness of Airrosti and TheraBand Exercises on Double-Crossed Syndrome in Smart Phone Users Shoulder
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Effectiveness of Airrosti and TheraBand Exercises on Pain and Disability on Double-Crossed Syndrome in Smart Phone Users Shoulder
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Airrosti
Brief Summary:
Double-crossed syndrome refers to a specific alignment of overactive and underactive muscles in the neck chest and shoulders AIRROSTI stands for Applied Integration for the Rapid Recovery of Soft Tissue Injuries This study aims to evaluate the effectiveness of Airrosti exercises combined with TheraBand exercises in reducing pain and disability in the neck and shoulders TheraBand exercise programs are commonly used to improve muscle activation However research on the effectiveness of AIRROSTI combined with TheraBand exercises for treating Double-Crossed Syndrome among smartphone users is limited and more evidence is needed to support their effectiveness
Detailed Description:
Research objective is to evaluate the effectiveness of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome To evaluate the combined effect of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome To compare the effect of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None